p53 Gene Mutations Occurring in Spontaneous Benign and Malignant Mammary Tumors of the Dog

Sixty-three cases of benign and malignant canine mammary tumors were analyzed to define the alteration of exons 5–8 for the p53 tumor suppressor gene using polymerase chain reaction direct sequence analysis with paraffin-embedded tissues. Four missense mutations were found in 38 benign mammary tumors (11%), and five missense (one tumor had two missense mutations) and one nonsense mutations were found in 25 mammary carcinomas (20%). These data suggest that the p53 gene alterations might be initiated at an early stage of canine mammary carcinogenesis and p53 mutations might be associated with malignancy. However, there was no evidence of any relationship between the p53 alterations and the histologic types of tumors or breeds of dogs.

[1]  Wojciech Makalowski,et al.  Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features , 1999, Oncogene.

[2]  Robert Brown,et al.  Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog , 1998, Oncogene.

[3]  B. Mayr,et al.  Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs. , 1998, American journal of veterinary research.

[4]  C. Cornelisse,et al.  P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog. , 1996, Anticancer research.

[5]  L. Holmberg,et al.  Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy , 1995, Nature Medicine.

[6]  R. Millikan,et al.  p53 mutations in benign breast tissue. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  B. Madewell,et al.  Sequence analysis of canine p53 in the region of exons 3-8. , 1995, Cancer letters.

[8]  J. Boyd,et al.  Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men. , 1995, Cancer research.

[9]  D. Schaid,et al.  p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis. , 1994, Oncogene.

[10]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[11]  P. Devilee,et al.  The canine p53 gene is subject to somatic mutations in thypoid carcinoma. , 1994, Anticancer research.

[12]  Thierry Soussi,et al.  TP53 tumor suppressor gene: A model for investigating human mutagenesis , 1992, Genes, chromosomes & cancer.

[13]  N. Lemoine,et al.  Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours. , 1991, Oncogene.

[14]  I Iu IUDIN,et al.  [Tumors of the mammary gland]. , 1955, Meditsinskaia sestra.

[15]  F. Hyde.  Tumors of Mammary Gland. , 1900 .

[16]  D. Cosgrove.  The breast , 1999, European Radiology.

[17]  A. Johnson,et al.  Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. , 1998, Carcinogenesis.

[18]  S. A. Goedegebuure,et al.  P53 gene mutations in osteosarcomas in the dog. , 1997, Cancer letters.

[19]  Thierry Soussi,et al.  Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects , 1997, Nucleic Acids Res..

[20]  K. Schellander,et al.  Sequence of an exon of the canine p53 gene--mutation in a papilloma. , 1994, The British veterinary journal.

[21]  J. Hampe,et al.  Tumours and dysplasias of the mammary gland. , 1974, Bulletin of the World Health Organization.